The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Abstract
Oxidative stress, an emerging risk factor for premature atherosclerosis and cardiovascular disease, mediates the formation of proinflammatory, pro-atherogenic oxidized low-density lipoprotein (oxLDL) in the arterial intima. Circulating HDL particles, and particularly small, dense, protein-rich HDL3, may provide potent protection of LDL in vivo from oxidative damage by free radicals in the arterial intima, resulting in the inhibition of the generation of proinflammatory oxidized lipids, primarily lipid hydroperoxides (LOOH) but also short-chain oxidized phospholipids (oxPL). HDL-mediated inactivation of LOOH involves initial transfer of phospholipid hydroperoxides (PLOOH) from LDL to HDL3, which is governed by the rigidity of the surface monolayer of HDL, and subsequent reduction of PLOOH by redox-active Met residues of apolipoprotein A-I (apoA-I) with the formation of phospholipid hydroxides (PLOH) and methionine sulphoxides. HDL-associated enzymes may in turn contribute to the hydrolytic inactivation of short-chain oxPL. Mounting evidence suggests that the integrated antioxidative activity of HDL appear to be defective in atherogenic dyslipidaemias involving low HDL-cholesterol levels; anomalies in the proteome and lipidome of HDL particles in dyslipidaemic patients may underlie such functional deficiency. Pharmacological normalization of HDL metabolism concomitantly with correction of circulating levels, composition and biological activities of HDL particles, with enrichment in apoA-I and reduction in HDL surface rigidity, may constitute an efficacious therapeutic approach to attenuate atherosclerosis in dyslipidaemic patients at high cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942
Robins, S. J., Collins, D., Wittes, J. T., Papademetriou, V., Deedwania, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., Wexler, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 921
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 715
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Self-citationBowry, V. W., Stanley, K. K., & Stocker, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10316 · Cited by 479
Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 477
Self-citationZalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
Self-citationDavidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Self-citationCalcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
Jakubowski, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3957 · Cited by 398
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
Kontush, A., & Chapman, M. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0500 · Cited by 342
Self-citationThe metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134275.90823.87 · Cited by 323
Oxidation of High Density Lipoproteins
Garner, B., Waldeck, A. R., Witting, P. K., Rye, K.-A., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6088 · Cited by 319
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Kontush, A., Therond, P., Zerrad, A., Couturier, M., Négre-Salvayre, A., de Souza, J. A., Chantepie, S., & Chapman, M. J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145672 · Cited by 229
Self-citationNob�court, E., Jacqueminet, S., Hansel, B., Chantepie, S., Grimaldi, A., Chapman, M. J., & Kontush, A. (2005) · Diabetologia · doi:10.1007/s00125-004-1655-5 · Cited by 220
Self-citationQuarck, R., De Geest, B., Stengel, D., Mertens, A., Lox, M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., et al. (2001) · Circulation · doi:10.1161/01.cir.103.20.2495 · Cited by 193
Goulinet, S., & Chapman, M. J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.786 · Cited by 191
Self-citationMarathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 173
The Role of High-Density Lipoproteins in Oxidation and Inflammation
Van Lenten, B. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00095-0 · Cited by 165
Gowri, M. S., Van der Westhuyzen, D. R., Bridges, S. R., & Anderson, J. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2226 · Cited by 164
Zerrad-Saadi, A., Therond, P., Chantepie, S., Couturier, M., Rye, K.-A., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194555 · Cited by 160
Self-citationOstos, M. A., Conconi, M., Vergnes, L., Baroukh, N., Ribalta, J., Girona, J., Caillaud, J.-M., Ochoa, A., & Zakin, M. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1023 · Cited by 158
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.001 · Cited by 144
Self-citationCombined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
Green, P. S., Vaisar, T., Pennathur, S., Kulstad, J. J., Moore, A. B., Marcovina, S. M., Brunzell, J. D., Knopp, R. H., Zhao, X.-Q., & Heinecke, J. W. (2008) · Circulation · doi:10.1161/circulationaha.108.770669 · Cited by 131
Souza, J. A., Vindis, C., Nègre‐Salvayre, A., Rye, K., Couturier, M., Thérond, P., Chantepie, S., Salvayre, R., Chapman, M. J., & Kontush, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00713.x · Cited by 128
Self-citationRibas, V., Sánchez‐Quesada, J. L., Antón, R. I., Camacho, M., Julve, J., Escolá‐Gil, J. C., Vila, L., Ordóñez‐Llanos, J., & Blanco‐Vaca, F. (2004) · Circulation Research · doi:10.1161/01.res.0000146031.94850.5f · Cited by 127
Tsimihodimos, V., Kakafika, A. I., Tambaki, A. P., Bairaktari, E. T., Chapman, M. J., Elisaf, M., & Tselepis, A. D. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200452-jlr200 · Cited by 118
Self-citationThorngate, F. E., Rudel, L. L., Walzem, R. L., & Williams, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1939 · Cited by 115
Novel Function of Lecithin-Cholesterol Acyltransferase
Goyal, J., Wang, K., Liu, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16231 · Cited by 114
Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E
Tangirala, R. K., Praticò, D., FitzGerald, G. A., Chun, S. H., Tsukamoto, K., Maugeais, C., Usher, D. C., Puré, E., & Rader, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003324200 · Cited by 114
HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Proudfoot, J. M., Barden, A. E., Loke, W. M., Croft, K. D., Puddey, I. B., & Mori, T. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800607-jlr200 · Cited by 112
Curtiss, L. K., Bonnet, D. J., & Rye, K. (2000) · Biochemistry · doi:10.1021/bi992902m · Cited by 110
Sparks, D. L., Davidson, W. S., Lund‐Katz, S., & Phillips, M. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26910 · Cited by 110
Ferretti, G., Bacchetti, T., Busni, D., Rabini, R. A., & CURATOLA, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031897 · Cited by 109
Christison, J. K., Rye, K., & Stocker, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41119-8 · Cited by 107
Perségol, L., Vergès, B. L., Foissac, M., Gambert, P., & Duvillard, L. (2006) · Diabetologia · doi:10.1007/s00125-006-0244-1 · Cited by 104
Raffaï, R. L., Loeb, S. M., & Weisgraber, K. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152613.83243.12 · Cited by 94
Girotti, A. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.004 · Cited by 92
Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X., Lambert, G. C., Rye, K.-A., Barter, P. J., Nicholls, S. J., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.047 · Cited by 92
Graham, A., Hassall, D. G., Rafique, S., & Owen, J. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00162-7 · Cited by 88
Apolipoprotein J: a membrane policeman?
Jordan, T. C., Witte, D. P., Aronow, B. J., & Harmony, J. A. K. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199204000-00004 · Cited by 85
Kontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118276.87061.00 · Cited by 79
Self-citationFormation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins
Panzenboeck, U., & Stocker, R. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.003 · Cited by 76
Teiber, J. F., Draganov, D. I., & Du, B. N. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400213-jlr200 · Cited by 76
Kriska, T., Marathe, G. K., Schmidt, J. C., McIntyre, T. M., & Girotti, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608135200 · Cited by 70
Perségol, L., Foissac, M., Lagrost, L., Athias, A., Gambert, P., Vergès, B. L., & Duvillard, L. (2007) · Diabetologia · doi:10.1007/s00125-007-0808-8 · Cited by 68
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite
Connelly, P. W., Draganov, D. I., & Maguire, G. F. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.010 · Cited by 68
Zhou, H., Tan, K. C. B., Shiu, S. W. M., & Wong, Y. M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm631 · Cited by 58
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
Boisfer, E., Stengel, D., Pastier, D., Laplaud, P. M., Dousset, N., Ninio, E., & Kalopissis, A. D. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30115-2 · Cited by 57
Increased methionine sulfoxide content of apoA-I in type 1 diabetes
Brock, J. W. C., Jenkins, A. J., Lyons, T. J., Klein, R. L., Yim, E., Lopes-Virella, M. F., Carter, R. E., Thorpe, S. R., & Baynes, J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800015-jlr200 · Cited by 50
Mashima, R., Yamamoto, Y., & Yoshimura, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32537-2 · Cited by 49
Vila, A., Korytowski, W., & Girotti, A. W. (2002) · Biochemistry · doi:10.1021/bi026467z · Cited by 48
Ferretti, G., Bacchetti, T., Moroni, C., Vignini, A., & CURATOLA, G. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.10.005 · Cited by 47
Perségol, L., Vergès, B. L., Gambert, P., & Duvillard, L. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600309-jlr200 · Cited by 45
Arbonés-Mainar, J. M., Navarro, M. Á., Carnicer, R., Guillén, N., Surra, J. C., Acín, S., Guzmán, M., Sarría, A. J., Arnal, C., Aguilera, M. P., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.010 · Cited by 42
Klimov, A. N., Kozhevnikova, K. A., Kuzmin, A. A., et al. (2001) · Biochemistry (Moscow) · doi:10.1023/a:1010203930470 · Cited by 32
Balstad, T. R., Holven, K. B., Ottestad, I. O., Otterdal, K., Halvorsen, B. L., Myhre, A. M., Ose, L., & Nenseter, M. S. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.050 · Cited by 20
Cited by
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Self-citationHDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 656
Ito, F., Sono, Y., & Ito, T. (2019) · Antioxidants · doi:10.3390/antiox8030072 · Cited by 535
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 471
Self-citationSoppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 407
Metadata
- Authors
- Kontush, A., & Chapman, M. J.
- Venue
- Current Opinion in Lipidology
- Published
- 2010-08
- Volume
- 21
- Issue
- 4
- Pages
- 312-318
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2052000579
- Cited by
- 293
- References
- 65
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.